GlobeNewswire: LDR Holding Corporation Contains the last 10 of 61 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T08:22:08ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2016/06/07/846602/0/en/Zimmer-Biomet-to-Acquire-LDR-to-Enhance-Innovation-and-Growth-of-Spine-Business.html?f=22&fvtc=4&fvtv=20275Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business2016-06-07T11:04:50Z<![CDATA[WARSAW, Ind. and AUSTIN, Texas, June 07, 2016 (GLOBE NEWSWIRE) -- Zimmer Biomet Holdings, Inc. (NYSE:ZBH) (SIX:ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ:LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion.  The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.]]>https://www.globenewswire.com/news-release/2016/06/02/845806/0/en/LDR-Announces-First-Surgeries-Using-ROI-C-Cervical-Cage-With-Titanium-Coating.html?f=22&fvtc=4&fvtv=20275LDR Announces First Surgeries Using ROI-C Cervical Cage With Titanium Coating2016-06-02T20:05:00Z<![CDATA[New Titanium Surface Treatment Provides Additional Option for Surgeons New Titanium Surface Treatment Provides Additional Option for Surgeons]]>https://www.globenewswire.com/news-release/2016/05/19/841789/0/en/LDR-Holding-Corporation-to-Present-at-UBS-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=20275LDR Holding Corporation to Present at UBS Global Healthcare Conference2016-05-19T20:05:00Z<![CDATA[AUSTIN, Texas, May 19, 2016 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be presenting at the UBS Global Healthcare Conference to be held from May 23-25, 2016 in New York, NY. LDR Holding’s presentation will take place on Wednesday, May 25, 2016 at 8:30 am Eastern Time.   ]]>https://www.globenewswire.com/news-release/2016/05/10/838572/0/en/LDR-Holding-Corporation-Reports-First-Quarter-2016-Results.html?f=22&fvtc=4&fvtv=20275LDR Holding Corporation Reports First Quarter 2016 Results2016-05-10T20:05:00Z<![CDATA[First Quarter Revenue Increased 8.4% Year-Over-Year to $42.4 million or 9.7% Constant Currency Global Mobi-C Growth of 28.8% Driven by U.S. Mobi-C Growth of 36.0%]]>https://www.globenewswire.com/news-release/2016/04/19/830396/0/en/LDR-Holding-Corporation-Announces-First-Quarter-2016-Conference-Call.html?f=22&fvtc=4&fvtv=20275LDR Holding Corporation Announces First Quarter 2016 Conference Call2016-04-19T20:05:00Z<![CDATA[AUSTIN, Texas, April 19, 2016 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that it will report financial results for the first quarter ended March 31, 2016 after the market close on Tuesday, May 10, 2016. The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time.]]>https://www.globenewswire.com/news-release/2016/03/29/823814/0/en/LDR-Announces-Publication-of-Long-Term-Clinical-Results-Showing-Superiority-of-Two-Level-Mobi-C-Cervical-Disc-to-ACDF-at-Five-Years.html?f=22&fvtc=4&fvtv=20275LDR Announces Publication of Long-Term Clinical Results Showing Superiority of Two-Level Mobi-C Cervical Disc to ACDF at Five Years2016-03-29T20:05:00Z<![CDATA[Journal of Neurosurgery: Spine Publishes Independent Peer-Reviewed Five-Year Follow-Up Comparison of Two-Level Cervical Disc Replacement versus ACDF Journal of Neurosurgery: Spine Publishes Independent Peer-Reviewed Five-Year Follow-Up Comparison of Two-Level Cervical Disc Replacement versus ACDF]]>https://www.globenewswire.com/news-release/2016/03/08/818019/0/en/LDR-Announces-Peer-Reviewed-Publication-Finding-Safety-and-Efficacy-of-One-Level-Mobi-C-Cervical-Disc-at-5-Years.html?f=22&fvtc=4&fvtv=20275LDR Announces Peer-Reviewed Publication Finding Safety and Efficacy of One-Level Mobi-C Cervical Disc at 5 Years2016-03-08T21:05:00Z<![CDATA[International Journal of Spine Surgery (IJSS) Publishes Comparison of One-Level Mobi-C Versus ACDF With Five-Year Follow-up International Journal of Spine Surgery (IJSS) Publishes Comparison of One-Level Mobi-C Versus ACDF With Five-Year Follow-up]]>https://www.globenewswire.com/news-release/2016/03/02/816357/0/en/LDR-Holding-Corporation-to-Present-at-Cowen-and-Company-Health-Care-Conference.html?f=22&fvtc=4&fvtv=20275LDR Holding Corporation to Present at Cowen and Company Health Care Conference2016-03-02T21:05:00Z<![CDATA[AUSTIN, Texas, March 02, 2016 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be presenting at the Cowen and Company 36th Annual Health Care Conference to be held from March 7-9, 2016 in Boston, MA. LDR Holding’s presentation will take place on Tuesday, March 8, 2016 at 8:00 am Eastern Time.]]>https://www.globenewswire.com/news-release/2016/02/17/811602/0/en/LDR-Holding-Corporation-Reports-Record-Revenue-for-Fourth-Quarter-and-Fiscal-Year-2015.html?f=22&fvtc=4&fvtv=20275LDR Holding Corporation Reports Record Revenue for Fourth Quarter and Fiscal Year 20152016-02-17T21:05:00Z<![CDATA[Fiscal Year Revenue Increased 16.4% Year-Over-Year to $164.5 Million or 21.3% Constant Currency Fiscal Year Revenue Increased 16.4% Year-Over-Year to $164.5 Million or 21.3% Constant Currency]]>https://www.globenewswire.com/news-release/2016/02/09/809105/0/en/LDR-Announces-Publication-of-Five-Year-Results-of-Cost-Utility-Analysis-of-Mobi-C-Cervical-Disc.html?f=22&fvtc=4&fvtv=20275LDR Announces Publication of Five-Year Results of Cost Utility Analysis of Mobi-C Cervical Disc2016-02-09T21:05:00Z<![CDATA[Study Finds Mobi-C Appears to be Highly Cost-Effective Compared With ACDF for Treating Two-Level Cervical Disc Disease Out to Five Years Study Finds Mobi-C Appears to be Highly Cost-Effective Compared With ACDF for Treating Two-Level Cervical Disc Disease Out to Five Years]]>